Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Hemorrhage | 8 | 2022 | 96 | 2.010 |
Why?
|
| Magnetic Resonance Imaging | 18 | 2023 | 1112 | 1.450 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 6 | 2022 | 89 | 1.130 |
Why?
|
| Tomography, X-Ray Computed | 11 | 2022 | 683 | 1.020 |
Why?
|
| Central Nervous System Cysts | 3 | 2017 | 6 | 0.950 |
Why?
|
| Cerebral Ventricles | 2 | 2016 | 17 | 0.780 |
Why?
|
| Radiosurgery | 1 | 2022 | 34 | 0.770 |
Why?
|
| Neoplasms, Second Primary | 1 | 2022 | 38 | 0.770 |
Why?
|
| Spinal Neoplasms | 1 | 2022 | 37 | 0.760 |
Why?
|
| Dermoid Cyst | 2 | 2017 | 6 | 0.680 |
Why?
|
| Sphenoid Sinus | 2 | 2016 | 14 | 0.660 |
Why?
|
| Intracranial Hemorrhages | 1 | 2018 | 13 | 0.590 |
Why?
|
| Respiratory Insufficiency | 1 | 2018 | 51 | 0.570 |
Why?
|
| Spinal Canal | 1 | 2017 | 8 | 0.560 |
Why?
|
| Cerebral Angiography | 2 | 2016 | 33 | 0.540 |
Why?
|
| Plasmacytoma | 1 | 2016 | 8 | 0.540 |
Why?
|
| Brain | 7 | 2023 | 1649 | 0.530 |
Why?
|
| Humans | 39 | 2023 | 27072 | 0.530 |
Why?
|
| Arachnoid Cysts | 1 | 2016 | 4 | 0.530 |
Why?
|
| Arabinonucleosides | 1 | 2016 | 7 | 0.510 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 13 | 0.510 |
Why?
|
| Postoperative Hemorrhage | 1 | 2016 | 23 | 0.510 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2016 | 65 | 0.500 |
Why?
|
| Spinal Cord Diseases | 1 | 2016 | 47 | 0.480 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 198 | 0.440 |
Why?
|
| Chin | 1 | 2011 | 2 | 0.380 |
Why?
|
| Mouth, Edentulous | 1 | 2011 | 3 | 0.380 |
Why?
|
| Hypesthesia | 1 | 2011 | 6 | 0.380 |
Why?
|
| Brain Ischemia | 2 | 2021 | 63 | 0.330 |
Why?
|
| Spinal Fusion | 1 | 2016 | 457 | 0.310 |
Why?
|
| Male | 20 | 2023 | 14772 | 0.280 |
Why?
|
| Female | 17 | 2020 | 15212 | 0.270 |
Why?
|
| Headache | 1 | 2006 | 35 | 0.260 |
Why?
|
| Adult | 12 | 2023 | 7831 | 0.250 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2020 | 34 | 0.230 |
Why?
|
| Middle Aged | 12 | 2020 | 8923 | 0.220 |
Why?
|
| Aged | 11 | 2023 | 8997 | 0.210 |
Why?
|
| Leukoencephalopathies | 1 | 2023 | 12 | 0.210 |
Why?
|
| Cranial Fossa, Middle | 1 | 2022 | 4 | 0.200 |
Why?
|
| Radiologists | 1 | 2022 | 8 | 0.200 |
Why?
|
| Encephalocele | 1 | 2022 | 22 | 0.200 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2014 | 29 | 0.200 |
Why?
|
| Blindness | 1 | 2022 | 8 | 0.190 |
Why?
|
| Discitis | 1 | 2022 | 3 | 0.190 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 135 | 0.190 |
Why?
|
| Electric Stimulation Therapy | 1 | 2021 | 41 | 0.190 |
Why?
|
| Mental Disorders | 1 | 2023 | 141 | 0.180 |
Why?
|
| Spine | 1 | 2022 | 108 | 0.180 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2021 | 64 | 0.180 |
Why?
|
| Rhabdoid Tumor | 1 | 2020 | 2 | 0.180 |
Why?
|
| Hyperglycemia | 1 | 2020 | 29 | 0.180 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2020 | 11 | 0.170 |
Why?
|
| Sensitivity and Specificity | 1 | 2022 | 482 | 0.170 |
Why?
|
| Hypoxia | 1 | 2020 | 32 | 0.170 |
Why?
|
| Blood Glucose | 1 | 2020 | 104 | 0.170 |
Why?
|
| Otitis Media | 1 | 2020 | 5 | 0.170 |
Why?
|
| Skull Base | 1 | 2020 | 34 | 0.160 |
Why?
|
| Blastomycosis | 1 | 2020 | 24 | 0.160 |
Why?
|
| Stents | 2 | 2011 | 82 | 0.160 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 117 | 0.150 |
Why?
|
| Vestibular Nerve | 1 | 2018 | 2 | 0.150 |
Why?
|
| Vestibular Neuronitis | 1 | 2018 | 2 | 0.150 |
Why?
|
| Cauda Equina | 1 | 2017 | 5 | 0.150 |
Why?
|
| Spinal Nerve Roots | 1 | 2017 | 15 | 0.140 |
Why?
|
| Vascular Malformations | 1 | 2017 | 5 | 0.140 |
Why?
|
| Hodgkin Disease | 1 | 2017 | 19 | 0.140 |
Why?
|
| Radiotherapy | 1 | 2017 | 31 | 0.140 |
Why?
|
| Neurology | 1 | 2018 | 37 | 0.140 |
Why?
|
| Quality of Life | 1 | 2022 | 629 | 0.140 |
Why?
|
| Critical Illness | 1 | 2018 | 117 | 0.140 |
Why?
|
| Artifacts | 2 | 2014 | 30 | 0.130 |
Why?
|
| Syringomyelia | 1 | 2016 | 7 | 0.130 |
Why?
|
| Arachnoid | 1 | 2016 | 10 | 0.130 |
Why?
|
| Spinal Stenosis | 1 | 2016 | 37 | 0.130 |
Why?
|
| Suction | 1 | 2016 | 40 | 0.130 |
Why?
|
| Oculomotor Muscles | 1 | 2015 | 3 | 0.120 |
Why?
|
| Optic Nerve Diseases | 1 | 2015 | 5 | 0.120 |
Why?
|
| Muscle Neoplasms | 1 | 2015 | 4 | 0.120 |
Why?
|
| Contrast Media | 3 | 2023 | 66 | 0.120 |
Why?
|
| Nerve Compression Syndromes | 1 | 2015 | 20 | 0.120 |
Why?
|
| Neuroimaging | 1 | 2016 | 126 | 0.120 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2014 | 11 | 0.110 |
Why?
|
| Reperfusion | 1 | 2014 | 7 | 0.110 |
Why?
|
| Metals | 1 | 2014 | 140 | 0.100 |
Why?
|
| Erdheim-Chester Disease | 1 | 2012 | 2 | 0.100 |
Why?
|
| Prostheses and Implants | 1 | 2014 | 154 | 0.100 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 348 | 0.100 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2016 | 313 | 0.100 |
Why?
|
| Algorithms | 1 | 2014 | 350 | 0.100 |
Why?
|
| Retrospective Studies | 5 | 2022 | 3538 | 0.100 |
Why?
|
| Mandible | 1 | 2011 | 12 | 0.090 |
Why?
|
| Putaminal Hemorrhage | 1 | 2011 | 1 | 0.090 |
Why?
|
| Prospective Studies | 3 | 2021 | 1778 | 0.090 |
Why?
|
| Putamen | 1 | 2011 | 19 | 0.090 |
Why?
|
| Neurologic Examination | 1 | 2011 | 100 | 0.090 |
Why?
|
| Lumbar Vertebrae | 1 | 2016 | 383 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 164 | 0.090 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2011 | 54 | 0.090 |
Why?
|
| Neurosurgical Procedures | 1 | 2011 | 122 | 0.080 |
Why?
|
| United States | 1 | 2016 | 2035 | 0.080 |
Why?
|
| Postoperative Complications | 2 | 2016 | 916 | 0.080 |
Why?
|
| Child | 2 | 2023 | 1295 | 0.080 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2008 | 2 | 0.080 |
Why?
|
| Heroin Dependence | 1 | 2008 | 9 | 0.080 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2009 | 19 | 0.080 |
Why?
|
| Dementia, Vascular | 1 | 2008 | 46 | 0.070 |
Why?
|
| Status Epilepticus | 1 | 2008 | 13 | 0.070 |
Why?
|
| Cerebrovascular Disorders | 1 | 2009 | 133 | 0.070 |
Why?
|
| Dominance, Cerebral | 1 | 2006 | 15 | 0.070 |
Why?
|
| Ependymoma | 1 | 2006 | 18 | 0.070 |
Why?
|
| Sacrum | 1 | 2006 | 24 | 0.070 |
Why?
|
| Ganglioneuroma | 1 | 2005 | 3 | 0.060 |
Why?
|
| Mediastinal Neoplasms | 1 | 2005 | 11 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 474 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 3 | 2009 | 34 | 0.060 |
Why?
|
| Computed Tomography Angiography | 1 | 2023 | 27 | 0.050 |
Why?
|
| Atrophy | 2 | 2018 | 91 | 0.050 |
Why?
|
| Head | 1 | 2023 | 23 | 0.050 |
Why?
|
| Administration, Intravenous | 1 | 2023 | 24 | 0.050 |
Why?
|
| Physical Examination | 1 | 2023 | 116 | 0.050 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2022 | 21 | 0.050 |
Why?
|
| Risk Factors | 2 | 2020 | 2302 | 0.050 |
Why?
|
| Implantable Neurostimulators | 1 | 2021 | 5 | 0.050 |
Why?
|
| Tomography | 1 | 2021 | 12 | 0.050 |
Why?
|
| Hypoglossal Nerve | 1 | 2021 | 6 | 0.050 |
Why?
|
| Fluoroscopy | 1 | 2022 | 48 | 0.050 |
Why?
|
| Image-Guided Biopsy | 1 | 2022 | 37 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2008 | 985 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2022 | 3485 | 0.040 |
Why?
|
| Middle Cerebral Artery | 2 | 2011 | 7 | 0.040 |
Why?
|
| Constriction, Pathologic | 2 | 2011 | 33 | 0.040 |
Why?
|
| Itraconazole | 1 | 2020 | 5 | 0.040 |
Why?
|
| Illinois | 1 | 2020 | 250 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2020 | 43 | 0.040 |
Why?
|
| Biopsy | 1 | 2020 | 201 | 0.040 |
Why?
|
| Decompression, Surgical | 1 | 2020 | 125 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 481 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 236 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2020 | 641 | 0.040 |
Why?
|
| Vertigo | 1 | 2018 | 8 | 0.040 |
Why?
|
| Hospitalization | 1 | 2020 | 300 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 785 | 0.040 |
Why?
|
| Biomarkers | 1 | 2020 | 562 | 0.040 |
Why?
|
| Young Adult | 2 | 2015 | 1994 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2022 | 1890 | 0.030 |
Why?
|
| Time Factors | 1 | 2020 | 1433 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1368 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2015 | 41 | 0.030 |
Why?
|
| Endovascular Procedures | 1 | 2014 | 33 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2014 | 54 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 75 | 0.030 |
Why?
|
| Acute Disease | 1 | 2014 | 176 | 0.030 |
Why?
|
| Supratentorial Neoplasms | 1 | 2011 | 3 | 0.020 |
Why?
|
| Skin | 1 | 2012 | 123 | 0.020 |
Why?
|
| Astrocytoma | 1 | 2011 | 17 | 0.020 |
Why?
|
| Basilar Artery | 1 | 2011 | 3 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2011 | 19 | 0.020 |
Why?
|
| Vertebral Artery | 1 | 2011 | 4 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2011 | 63 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 4777 | 0.020 |
Why?
|
| Radiography | 1 | 2011 | 619 | 0.020 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2009 | 1 | 0.020 |
Why?
|
| Intracranial Aneurysm | 1 | 2009 | 41 | 0.020 |
Why?
|
| Psychomotor Disorders | 1 | 2008 | 11 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2009 | 53 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2008 | 77 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2006 | 48 | 0.020 |
Why?
|
| Neoplasms, Adipose Tissue | 1 | 2005 | 1 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 879 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2008 | 1196 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 1792 | 0.010 |
Why?
|